inmune bio phase 2 clinical trial of xpro in alzheimer's disease
Published 2 years ago • 397 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
2:12
the inmune bio approach to alzheimer's disease
-
59:30
xpro1595 webinar on expanded phase 1b data in patients with alzheimer’s disease
-
9:17
phase ii trial of xpro1595 for the treatment of alzheimer’s disease
-
1:44
how xpro1595 ("xpro") is unique to other tnf inhibitors
-
51:31
webinar on results of xpro in ad showing improvements in white matter pathology and decrease in ptau
-
0:59
our approach to alzheimer's disease
-
11:13
inside inmune bio | episode 2 - tnf "the master cytokine"
-
54:42
webinar on xpro1595 phase ib interim data of neuroinflammation in patients with alzheimer's disease
-
3:04
viewing alzheimer's as an immunological disease with symptoms of neurodegeneration
-
2:36
alzheimer's disease
-
2:05
targeting neuroinflammation in alzheimer's disease
-
2:40
neuroinflammation & alzheimer's disease
-
2:46
introduction to inmune bio
-
2:04
xpro1595
-
3:41
xpro1595 patient experience
-
10:02
clinical trial for alzheimer's disease
-
46:10
"improving white matter integrity in alzheimer's disease" inmune bio (nasdaq:inmb) ceo & cfo 9-3-21
-
12:15
inside inmune bio | episode 4 - biomarkers